Impacting Management of Chronic Kidney Disease Through Primary Care Practice Audits: A Quality Improvement Study

被引:3
|
作者
Mosa, Alexander I. [1 ,2 ,5 ]
Watts, Don [2 ]
Tangri, Navdeep [3 ,4 ]
机构
[1] McMaster Univ, Fac Hlth Sci, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[2] Khure Hlth, Toronto, ON, Canada
[3] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada
[4] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Family Med, Winnipeg, MB, Canada
[5] McMaster Univ, McMaster Hlth Sci Ctr, Fac Hlth Sci, Michael G DeGroote Sch Med, 1200 Main St West, Hamilton, ON L8N3Z5, Canada
关键词
kidney failure risk equation; risk stratification; EHR; clinical decision support software; quality improvement; IMPLEMENTATION; RISKS; DEATH; CKD;
D O I
10.1177/20543581221144840
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background:Risk prediction tools are important in chronic disease management, but their implementation into clinical workflow is often limited by lack of electronic health record (EHR)-linked solutions. Objective:To implement the Khure Health (KH) clinical decision support platform with an artificial intelligence (AI)-enabled algorithm for chronic kidney disease (CKD) risk detection in 201 primary care provider practices across Ontario. Design:Multi-practice quality improvement study. Setting:The study was conducted in Ontario, Canada. Participants:201 primary care practices. Measurements:Per-practice CKD risk stratification and clinician action. Methods:Data for estimated glomerular filtration rate (eGFR), albuminuria, demographics, and comorbid conditions were extracted from the EHR using KH's natural language processing (NLP) algorithms. Patients already on dialysis, visiting a nephrologist, older than 85, or already on a sodium-glucose cotransporter 2 inhibitor (SGLT2i) were excluded. The remaining individuals were risk stratified using the kidney failure risk equation, presence or absence of cardiovascular disease (CVD), or other comorbid conditions. A dashboard with disease-specific educational information and links to the EHRs of the identified patients was created. Results:We screened 361 299 individuals and identified 8194 patients with CKD Stage 3 at risk for progression or cardiovascular events. A total of 620 individuals were at high risk for CKD progression or CVD, and 2592 were at intermediate risk. A total of 2010 individuals (10 patients per practice) at high or moderate risk were selected for a chart audit, and appropriate additional testing (repeat eGFR or albuminuria) or prescription of disease-modifying therapy occurred in 24.32% of these patients. Limitations:Data on comorbidities, medications, or demographic variables are not available for presentation or statistical analysis due to privacy legislation and primary care provider (PCP) custodianship over EHR data. Conclusion:An AI-enabled EHR clinical decision support application that can detect and risk stratify patients with CKD can enable improved laboratory testing and management. Larger trials of clinical decision support and practice audit applications will be needed to impact CKD management nationally.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Managing chronic kidney disease in primary care: a quality improvement study
    Thomas, Nicola
    Loud, Fiona
    [J]. RENAL SOCIETY OF AUSTRALASIA JOURNAL, 2012, 8 (03) : 152 - 157
  • [2] Quality of chronic kidney disease management in primary care: a retrospective study
    Van Gelder, Vincent A.
    Scherpbier-De Haan, Nynke D.
    De Grauw, Wim J. C.
    Vervoort, Gerald M. M.
    Van Weel, Chris
    Biermans, Marion C. J.
    Braspenning, Joze C. C.
    Wetzels, Jack F. M.
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2016, 34 (01) : 73 - 80
  • [3] Enhancing primary care capacity in chronic kidney disease management: a quality improvement educational initiative
    Smekal, Michelle D.
    Bello, Aminu K.
    Donald, Maoliosa
    Zaidi, Deenaz
    McBrien, Kerry
    Nicholson, Katrina
    Novak, Ellen
    Hemmelgarn, Brenda
    [J]. BMJ OPEN, 2021, 11 (11):
  • [4] Quality of Chronic Kidney Disease Management in Canadian Primary Care
    Bello, Aminu K.
    Ronksley, Paul E.
    Tangri, Navdeep
    Kurzawa, Julia
    Osman, Mohamed A.
    Singer, Alexander
    Grill, Allan K.
    Nitsch, Dorothea
    Queenan, John A.
    Wick, James
    Lindeman, Cliff
    Soos, Boglarka
    Tuot, Delphine S.
    Shojai, Soroush
    Brimble, K. Scott
    Mangin, Dee
    Drummond, Neil
    [J]. JAMA NETWORK OPEN, 2019, 2 (09)
  • [5] Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review
    Gallagher, Hugh
    de Lusignan, Simon
    Harris, Kevin
    Cates, Christopher
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2010, 60 (575):
  • [6] What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial
    Nihat, Akin
    de Lusignan, Simon
    Thomas, Nicola
    Tahir, Mohammad Aumran
    Gallagher, Hugh
    [J]. BMJ OPEN, 2016, 6 (04):
  • [7] DEVELOPMENT OF A QUALITY MEASURE SET FOR CHRONIC KIDNEY DISEASE CARE IN PRIMARY CARE PRACTICE
    Litvin, Cara
    Ornstein, Steven M.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S161 - S161
  • [8] QUALITY OF CHRONIC KIDNEY DISEASE CARE IN PRIMARY CARE
    Allen, Adrienne
    Forman, John
    Orav, John
    Bates, David
    Denker, Bradley
    Sequist, Thomas
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 373 - 373
  • [9] Primary Care Management of Chronic Kidney Disease
    Adrienne S. Allen
    John P. Forman
    E. John Orav
    David W. Bates
    Bradley M. Denker
    Thomas D. Sequist
    [J]. Journal of General Internal Medicine, 2011, 26 : 386 - 392
  • [10] Primary Care Management of Chronic Kidney Disease
    Allen, Adrienne S.
    Forman, John P.
    Orav, E. John
    Bates, David W.
    Denker, Bradley M.
    Sequist, Thomas D.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (04) : 386 - 392